Firmoscan
Active08018355Private limited companyHook

ALIMERA SCIENCES LIMITED

D42/100

Owned by Ani Pharmaceuticals, Inc. (75–100%)

Companies HouseCompanies House
01

Summary

Generated from filed data · no estimates

ALIMERA SCIENCES LIMITED is an active private limited company (company number 08018355) incorporated on 3 April 2012, registered in Hook. Its registered activity is other business support service activities n.e.c. (SIC 82990). Latest full accounts cover the period ending 31 December 2024, showing net assets of −£34.68m and cash of £1.18m, with 29 employees on average. Turnover was £18.61m and profit for the year −£15.13m. Net assets fell 68% on the prior period (−£20.59m).

Peer position · net assets

By net assets it sits in the bottom quarter of 2,397 comparable companies in Reading (median £3,457, upper quartile £52k).

02

Key dates

Incorporated
3 April 201214 yrs ago
Next accounts due
30 September 202622 days overdue
Confirmation statement due
17 April 2027in 177 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

03

Activity

SIC 82990
Other business support service activities n.e.c.
Accounts type
Full
Size band
SmallCompanies Act thresholds
04

Financials

3 periods on record · latest ending 31 December 2024
Net assets
−£34.68m
vs Dec 2023
Cash at bank
£1.18m
+26%vs Dec 2023
Turnover
£18.61m
+40%vs Dec 2023
Employees
29
−3%vs Dec 2023
Net assets
−£34.68m
Cash at bank
£1.18m
Turnover
£18.61m
Profit for the year
−£15.13m
Average employees
29
Filed accounts by period, newest first
Period endNet assetsCashDebtorsCreditors <1yTurnoverProfitEmployees
31 December 2024−£34.68m£1.18m—£10.63m£18.61m−£15.13m29
31 December 2023−£20.59m£942k—£5.52m£13.27m−£10.27m30
1 January 2023———————
Current ratio1.66Comfortable
Net margin-81.3%Profit for the year ÷ turnover
Cash per employee£41kCash ÷ average employees

Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.

05

Firmoscan score

Rules-based · every point shows its evidence
42 / 100 · grade D
EDCBA
Score breakdown
50Starting scoreEvery scored company starts here
−15Negative net assetsNet assets £-34,680,918 at 2024-12-31
−8Net assets falling-68.5% vs prior period
+8Comfortable liquidityCurrent ratio 1.66
+4Cash reservesCash £1,184,741
+5Multi-year filing history3 periods on record
+8EstablishedIncorporated 2012-04-03 (15 years)
−10Accounts overdueDue 2026-09-30
42Score, grade D

A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice. How the score is computed.

06

Ownership and control

1 active · 1 other
  • Ani Pharmaceuticals, Inc.
    corporate entity, Minnesota · since 16 September 2024
    • owns 75–100% of shares
    • holds 75–100% of voting rights
    • can appoint or remove directors
  • Alimera Sciences, Inc.
    corporate entity, Georgia · since 6 April 2016 · ceased 16 September 2024
    • owns 75–100% of shares
    • holds 75–100% of voting rights
    • can appoint or remove directors

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.

07

Timeline

Newest first
  1. Confirmation statement duein 177 days
  2. Next accounts due22 days overdue
  3. Accounts period endNet liabilities £34.68m · full accounts
  4. Accounts period endNet liabilities £20.59m · full accounts
  5. Accounts period end
  6. Incorporated
08

Similar companies in Reading

Same activity (other business support service activities n.e.c.), closest in incorporation date

All companies incorporated on 3 April 2012 · in Apr 2012.

09

Reminders for ALIMERA SCIENCES LIMITED

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.